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NIPBL, a cohesin loader, has been implicated in tran-
scriptional control and genome organization. Muta-
tions in NIPBL, cohesin, and its deacetylase HDAC8
result in Cornelia de Lange syndrome.We report acti-
vation of the RNA-sensing kinase PKR in human
lymphoblastoid cell lines carrying NIPBL or HDAC8
mutations, but not SMC1A or SMC3 mutations.
PKR activation can be triggered by unmodified
RNAs. Gene expression profiles in NIPBL-deficient
lymphoblastoid cells and mouse embryonic stem
cells reveal lower expression of genes involved in
RNA processing and modification. NIPBL mutant
lymphoblastoid cells show reduced proliferation
and protein synthesis with increased apoptosis, all
of which are partially reversed by a PKR inhibitor.
Non-coding RNAs from an NIPBL mutant line had
less m6A modification and activated PKR activity
in vitro. This study provides insight into themolecular
pathology of Cornelia de Lange syndrome by estab-
lishing a relationship between NIPBL and HDAC8
mutations and PKR activation.
INTRODUCTION
Chromosomes undergo structural changes to facilitate gene
expression and genome organization. These changes are regu-
lated, in part, by structural maintenance of chromosome (SMC)
proteins. SMC proteins are evolutionarily conserved complexes
that regulate the structural and functional organization of chro-
mosomes from bacteria to humans (Nasmyth and Haering,
2005). SMC proteins are an essential component of complexes
that organize chromosomes in the nucleus through the utiliza-
tion of energy from ATP hydrolysis (Hirano, 2006). One of the
SMC complexes, cohesin, is composed of four subunits
including a heterodimer of SMC1A and SMC3 along with the
kleisin RAD21. Cohesin generates cohesion of sister chroma-
tids, which holds sister chromatids together from S phase until
mitosis. The cohesin complex is crucial for various biological
processes, such as chromosome segregation, condensation,gene expression, and double-strand break repair (Jeppsson
et al., 2014).
The loading of cohesin complexes is facilitated by the loading
factor Nipped B-like protein (NIPBL) or Scc2, a budding yeast or-
tholog. Genome-wide chromatin immunoprecipitation (ChIP)
studies show that NIPBL co-localizes with both cohesin (Kagey
et al., 2010) and condensin II (Dowen et al., 2013) complexes.
Mutations in NIPBL lead to Cornelia de Lange syndrome
(CdLS; OMIM: 122470; Krantz et al., 2004; Tonkin et al., 2004).
CdLS is a genetic disorder distinguished by craniofacial dysmor-
phism, abnormal upper limb development, delayed growth, mild
to severe cognitive impairment, and multiple organ malforma-
tions (Dorsett and Krantz, 2009). Together with CdLS, other
multisystem developmental disorders resulting from mutations
that affect cohesin, such as Roberts syndrome (RBS; OMIM:
268300), have been termed cohesinopathies. About 60% of
CdLS cases are characterized by dominant heterozygous muta-
tions in NIPBL. Mutations in SMC1A, SMC3, HDAC8 (a cohesin
deacetylase), and RAD21 also cause CdLS or CdLS-like syn-
dromes (Mannini et al., 2013). NIPBL mutations associated
with CdLS are mostly loss-of-function mutations, and there is a
positive correlation between the severity of the mutation and
the phenotype (Mannini et al., 2013). Despite the importance of
NIPBL in sister chromatid cohesion, cells derived from CdLS pa-
tients do not show high rates of aneuploidy (Kaur et al., 2005),
indicating that the level of sister chromatid cohesion is sufficient
for chromosome segregation. This raises the possibility that
NIPBL may alter chromatin in a way that impinges on additional
processes, and dysfunction in these processes underlies CdLS.
Emerging evidence indicates that cohesin and NIPBL have
important functions in gene expression. InDrosophila, mutations
in Nipped B affect the activation of homeobox genes that require
long-distance interactions between enhancers and promoters,
such as cut and Ultrabithorax (Rollins et al., 1999). Recently, it
has been reported that NIPBL and Mediator regulate gene
expression in developing limbs in zebrafish (Muto et al., 2014).
A mutation in SCC2 in budding yeast was associated with the
loss of nucleosome-free regions (NFRs) at Scc2-bound genes
(Lopez-Serra et al., 2014), providing a possible mechanism by
which mutations in SCC2might affect multiple chromatin-based
processes. The same mutation in SCC2 was found to compro-
mise the biogenesis of non-coding (nc)RNAs and translational fi-
delity (Zakari et al., 2015a). A previous study examining geneCell Reports 14, 93–102, January 5, 2016 ª2016 The Authors 93
Figure 1. NIPBL Binds to and Regulates the
Expression of RNA-Processing Genes in
Human LCLs
(A) Gene ontology (GO) analysis of the promoters/
TSSs at which NIPBL binds in LCLs shows
enrichment for genes involved in RNAmodification
and splicing. The x axis values (in logarithmic
scale) correspond to the false discovery rate
(FDR). The numbers next to each bar indicate the
total number of genes differentially expressed of
the total number of genes with that GO term.
(B) NIPBLmetagene-binding profiles at TSSs were
generated using publicly available ChIP-seq data
from LCLs for four gene groups (mRNA-, tRNA-,
and rRNA-processing genes and random genes).
Numbers in parentheses indicate the number of
genes analyzed.
(C) The heatmap shows the expression levels of
mRNA-, tRNA-, and rRNA-processing genes inWT
andNIPBL-MS LCLs. The average log2 expression
value is displayed.
(D) The data from (C) are shown as a bar plot along
with the results of a t test. The expression of the
group of random genes corresponding to those in
(B) was not significantly different inWT andNIPBL-
MS LCLs.
See also Figures S1 and S2 and Table S1.expression in lymphoblastoid cell lines (LCLs) derived from pa-
tients with CdLS suggested cohesin may promote gene expres-
sion (Liu et al., 2009). Results from these studies underscore the
importance of NIPBL and cohesin as regulators of gene expres-
sion and further suggest CdLS may be caused by changes in
gene expression (Zakari et al., 2015b). However, the precise mo-
lecular pathogenesis of CdLS is largely unclear.
We report here that the generation of aberrant RNAs may
trigger the PKR-mediated stress response in LCLs derived
from patients with CdLS. The activation of PKR is associated
with reduced proliferation and protein synthesis and an increase
in apoptosis. These defects are partially rescued by inhibiting
PKR. Our results reveal that NIPBL supports a gene expression
program that prevents the activation of the PKR kinase. Further-
more, PKR may be a useful target when considering possible
therapies for CdLS.RESULTS
With over 60% of CdLS cases associated withNIPBLmutations,
the etiology of CdLS can likely be at least partially elucidated by
studying the loss of function of NIPBL. To investigate the poten-
tial functions of NIPBL, we first analyzed the publicly available
data of ChIP followed by massive parallel deep sequencing
(ChIP-seq) of NIPBL in human LCLs (Sequence Read Archive
[SRA]: ERR139553). We examined the genes whose promoters
are bound by NIPBL in LCLs with genome-wide gene ontology
(GO) analysis. As shown in Figure 1A, the first few significantly
enriched GO terms relate to gene expression and RNAmodifica-
tion. NIPBL firmly aligns with the transcription start site (TSS) of
protein-coding genes in LCLs (Liu et al., 2009; Figure S1).
Indeed, NIPBL has been implicated in gene expression (Dorsett94 Cell Reports 14, 93–102, January 5, 2016 ª2016 The Authorsand Merkenschlager, 2013). We decided to focus on RNA modi-
fication and processing.
We previously reported that Scc2 is important for rRNA modi-
fication in budding yeast (Zakari et al., 2015a). We divided the
RNA-processing genes into three different groups: mRNA-,
tRNA-, and rRNA-processing genes. The binding of NIPBL to
the promoter/TSS of various RNA-processing gene groups is de-
picted in the metagene analysis (Figure 1B). NIPBL preferentially
binds to actively transcribed genes, with a positive correlation
between its binding intensity at the promoter/TSS and expres-
sion levels of genes whose promoter/TSS are bound by NIPBL
(Figure S1B). We also analyzed the publicly available NIPBL
ChIP-seq data from mouse embryonic stem cells (mESCs).
Consistently, the GO term analysis of genes whose promoter is
bound by NIPBL in mESCs also indicates that NIPBL binds to
the promoter of both the coding mRNA- and ncRNA-processing
genes, such as tRNA-, mRNA-, and rRNA-processing genes
(Figure 2A). In agreement with data from LCLs, NIPBL also binds
to the promoter/TSS of genes involved in RNA processing in
mESCs (Figure 2B). Together, these data suggest NIPBL binds
at promoters of RNA-processing genes in mouse and human
cells, giving it the potential to regulate expression of those
genes.
We next asked whether NIPBL could promote expression of
RNA-processing genes. We performed RNA sequencing (RNA-
seq) of the LCL carrying an NIPBL missense (NIPBL-MS) muta-
tion (6893G > A; R2298H) generated from an individual with
CdLS together with a wild-type (WT) control line from a healthy
individual. Overall, 2.7%of genes (880/32,994) were differentially
expressed. As shown in Figure 1C, the expression of mRNA-,
tRNA-, and rRNA-processing genes was reduced in the
NIPBL-MS LCL. The reduced expression for each group was
statistically significant (Figure 1D). Also, the GO term RNA
Figure 2. NIPBL Binds to and Regulates the
Expression of RNA-Processing Genes in
mESCs
(A) GO analysis of the promoters/TSSs at which
NIPBL binds shows enrichment for RNA-pro-
cessing genes in mESCs. The x axis values (in
logarithmic scale) correspond to the FDR. The
numbers next to each bar indicate the total num-
ber of genes differentially expressed of the total
number of genes with that GO term.
(B) NIPBLmetagene-binding profiles at TSSs were
generated using publicly available ChIP-seq data
from mESC for four gene groups (mRNA-, tRNA-,
and rRNA-processing genes and random genes).
NIPBL binds at the TSS of RNA-processing genes.
Numbers in parentheses indicate the number of
genes analyzed.
(C) The heatmap shows the expression levels of
mRNA-, tRNA-, and rRNA-processing genes after
GFP (control) or Nipbl knockdown in mESCs. The
average log2 expression value is displayed.
(D) The data from the heatmap in (C) are shown as
a bar plot along with the results of a t test. The
expression of the group of random genes corre-
sponding to those in (B) was not significantly
different in GFP and Nipbl knockdown mESCs.
See also Figure S3 and Table S2.processing or modification was significantly enriched for the
downregulated genes (false discovery rate [FDR] < 3.18e4).
To confirm the lower expression of the RNA-processing genes
in NIPBL-MS LCLs, we selected 12 RNA-processing genes
from the heatmap in Figure 1C for qPCR and observed signifi-
cantly decreased expression for all of them (Figure S2). We
observed similar patterns of significantly reduced expression
of the RNA-processing genes in mESCs with small hairpin RNA
(shRNA) knockdown of Nipbl compared to that of GFP control
(Figures 2C and 2D), by examining the publicly available data
(Kagey et al., 2010). We wanted to confirm the reduced expres-
sion of RNA-processing genes in mESCs by qPCR. We per-
formed shRNA-mediated knockdown of Nipbl in mESCs, and
we confirmed the knockdown by both qPCR and western blot-
ting (Figures S3A and S3B). We picked 12 RNA-processing
genes from the heatmap in Figure 2C and confirmed their lower
expression upon knockdown of Nipbl in mESCs (Figure S3C).
NIPBL seems to be important for activating the expression of
RNA-processing genes in LCLs and mESCs.
Amousemodel for CdLS that carries a heterozygous knockout
of Nipbl has been developed previously (Kawauchi et al., 2009).
To gain insights into the molecular etiology of CdLS, mouse em-
bryonic fibroblasts (MEFs) were isolated from Nipbl+/ mice and
their WT littermates. We identified differential gene expression in
the transcriptomes of WT and mutant MEFs by RNA-seq. Sur-
prisingly, we observed a significant upregulation of immune
stress response genes, manifested by some proinflammatory
genes, toll-like receptors, and complement factors (Figure 3A).
Consistently, GO term analysis indicated that terms associated
with immune stress response were the most significantly en-
riched (Figure 3B). The inter-relationship between the enriched
GO terms is depicted in the clusters shown in Figure 3C, with
the generality of GO terms being immune response and stressresponse. Taken together, the results indicated that Nipbl+/
MEFs exhibit an upregulation of immune stress response.
Consistent with the Nipbl+/ MEFs, we observed a significant
upregulation of immune response genes in the NIPBL-MS LCL
(FDR < 5.43e3) (Figure 4A). Surprised by the results, we
wondered if this signature was connected to the generation of
aberrant RNAs.
We speculated that the upregulated immune signature could
be a causal effect of the downregulation of RNA-processing
genes. It has been reported that RNA with less processing or
modification could lead to an immune response. In fact, modifi-
cations in RNA provide a basis for various immune sensors to
distinguish between self-RNAs and pathogenic RNAs (Nallagatla
et al., 2008). We hypothesized that the decreased expression of
RNA-processing genes could generate a stress response due to
the generation of RNAs with processing, modification, or folding
defects, thereby causing an immune response. A central player
in sensing aberrant RNAs is the interferon-induced protein ki-
nase PKR, which is also a key component for innate immunity
(Nallagatla et al., 2007). Indeed, we found that the activity of
PKR, indicated by phosphorylated PKR (p-PKR), was increased
in NIPBL-MS cells and also in other LCLs carrying an NIPBL
frameshift mutation (NIPBL-FS) or an NIPBL nonsense mutation
(NIPBL-NS) (Figure 4B).
PKR is one of four mammalian kinases that phosphorylate eu-
karyotic initiation factor 2-a subunit (eIF2a) in response to stress
signals. PKR is activated mainly in response to viral infection
(Holcik and Sonenberg, 2005). PKR is a key component of innate
immunity that recognizes and binds to pathogenic RNAs. The
interaction of RNAs with PKR promotes and stabilizes its dimer-
ization. PKR then undergoes auto-phosphorylation and subse-
quently phosphorylates eIF2a to shut off general translation,
while translation of the ATF4 stress response transcription factorCell Reports 14, 93–102, January 5, 2016 ª2016 The Authors 95
Figure 3. A Stress Response Signature in
Nipbl+/ MEFs
(A) Heatmap showing the differential expression of
genes between WT and mutant (n = 3). Key
developmental genes and immune response
genes are downregulated and upregulated,
respectively, upon Nipbl haploinsufficiency.
(B) Top 10 enriched GO terms associated with the
2-fold higher expressed genes in mutant MEFs are
shown.
(C) GO term clustering shows the inter-relationship
between different GO terms for the higher ex-
pressed genes. The generality of the GO terms
is indicated by the bubble radius, where larger
bubbles represent broader terms and smaller
bubbles imply more specific terms. The intensity
of color represents the significance of enrich-
ment, with darker indicating more significance.
The thickness of the lines linking the GO terms
reflects the significance of the relationship be-
tween them.is upregulated (Hinnebusch, 2005). Consistently, the levels of p-
eIF2a and ATF4 in NIPBL mutant LCLs were upregulated (Fig-
ure 4B), further suggesting that the PKR-signaling cascade
was activated in the mutant LCLs. We found that the PKR-
signaling cascade also was elevated in Nipbl+/ MEFs (Fig-
ure S4). Additionally, a similar signature for p-PKR, p-eIF2A,
and ATF4 was observed in LCLs carrying HDAC8 missense
(7P and 98P) mutations (958G > A; G320R and 539A > G;
H180R, respectively) (Figure 4B). Interestingly, the PKR signa-
ture was not observed in LCLs carrying a mutation in SMC1A
(1487G > A; R496H) or SMC3 (1464-1466del) (Figure 4B). These
results suggest PKR activation may be associated with some
CdLS mutations, but not others. These results may provide a
molecular distinction between SMC mutations and mutations
in the SMC regulators HDAC8 and NIPBL.
Increased PKR activity inhibits translation by blocking the initi-
ation of protein synthesis through the phosphorylation of eIF2a.
Thus, pharmacological inhibition of PKR could represent an
attractive strategy for restoring translation. Inhibitors of PKR
have been identified, including 7-desacetoxy-6,7-dehydrogedu-
nin (7DG). The specificity of 7DG has been tested and confirmed;
mouse cells treated with 7DG phenocopy cells with RNAi knock-
down of PKR (Hett et al., 2013). Our western blot results indi-
cated that 7DG can inhibit the PKR-signaling pathway by
reducing the levels of p-PKR and eIF2a and the expression of
ATF4 in the NIPBL-MS LCL (Figure 4C). Moreover, 35S methio-
nine metabolic labeling assays showed a significant increase in
protein synthesis in the NIPBL-MS and HDAC8 mutant LCLs
upon treatment with 7DG (Figure S5A).
We treated LCLswith 7DG to test for additional rescue effects.
It has been shown that the activation of PKR induces apoptosis
(Srivastava et al., 1998). As shown in Figures 4D and 4E, both the
NIPBL-MS and the NIPBL-NS LCLs demonstrated reduced
growth in culture, with a concomitant propensity to undergo96 Cell Reports 14, 93–102, January 5, 2016 ª2016 The Authorsapoptosis. The NIPBL-FS had no obvious growth or proliferation
phenotype (data not shown). We treated NIPBL-MS and NIPBL-
NS LCLs with 7DG. As shown in Figures 4D and 4E, both the
slower proliferation and the elevated levels of apoptosis in the
NIPBL-MS and NIPBL-NS LCLs were significantly reversed by
7DG (300 mM). The partial, but remarkable, rescue of NIPBL-
MS and NIPBL-NS LCLs by 7DG indicated that PKR activation
contributes significantly to the phenotypes associated with the
NIPBL mutant LCLs. Moreover, 7DG could significantly atten-
uate the increased levels of reactive oxygen species (ROS)
present in theNIPBL-MS andNIPBL-NS LCLs (Figure 4F). These
results raise an exciting possibility that PKR inhibition may have
potential therapeutic value in the management of CdLS.
To test the hypothesis that aberrant RNAs are a source of
stress in the NIPBL mutant LCLs, we sought to further charac-
terize RNA biogenesis. Since PKR directly interacts with RNA
(Hinnebusch, 2005), we hypothesized that there would be
increased levels of aberrant RNAs inNIPBLmutant LCLs caused
by defects in RNA processing, thus activating PKR. Since RNAs
undergo extensive chemical modifications (Cantara et al., 2011),
we reasoned that RNAs from NIPBL mutant LCLs may have
modification defects. Unmodified RNAs are potent activators
of PKR (Nallagatla and Bevilacqua, 2008). We examined one
modification in particular, N6-methyladenosine (m6A), an adeno-
sine modification catalyzed by methyltransferases such as
METTL3 and METTL14 (Liu et al., 2014). m6A was selected for
study because it exists in most of the RNAs in a variety of organ-
isms. The abundance of m6A throughout the transcriptome
(about 7,000 mRNAs and over 300 ncRNAs in the mammalian
genome) has been demonstrated bym6A profiling from two inde-
pendent studies (Dominissini et al., 2012; Meyer et al., 2012).
Knockdown of eitherMETTL3 orMETTL14 results in a reduction
in total m6A levels in human cells (Dominissini et al., 2012; Liu
et al., 2014).
Figure 4. PKR and eIF2a Phosphorylation
and Expression of ATF4 Are Elevated in
NIPBL Mutant LCLs
(A) The heatmap shows an upregulation of immune
response genes in NIPBL-MS LCLs. The average
log2 expression value is displayed.
(B) There is increased p-PKR, p-eIF2a, and ATF4 in
LCLs derived from patients with NIPBL-MS, -NS,
and -FS mutations and HDAC8 mutations (98P
and 7P), but not from LCLs with cohesin SMC1
missense (SMC1-MS) or SMC3 missense (SMC3-
MS) mutations.
(C) 7DG treatment can inhibit the PKR-signaling
cascade, as shown by reduced levels of phos-
phorylation of PKR and eIF2a as well as the
reduced levels of ATF4.
(D) The NIPBL-MS and NIPBL-NS LCLs show poor
cell proliferation, which is partially rescued by treat-
ment with 7DG (300 nM). Error bars represent SEM.
(E) The NIPBL-MS and NIPBL-NS LCLs have
elevated levels of apoptosis and lower viability,
both of which are rescued by treatment with 7DG.
(F) NIPBL-MS and NIPBL-NS LCLs have elevated
levels of ROS, which are partially reversed
by 7DG treatment. *p < 0.05, **p < 0.01,
and ***p < 0.001 compared to WT; yp < 0.05 and
yyp < 0.01 compared to NIPBL-MS;Ap < 0.05 and
AAp < 0.01 compared to NIPBL-NS. All experi-
ments were performed with n = 3–4. Error bars
represent SEM.
See also Figures S4 and S5.We found that the expression of both METTL3 and METTL14
was downregulated in the NIPBL-MS LCL compared to a WT
LCL (Figures 5A and 5B). There was no significant difference in
METTL3 and METTL14 protein levels among SMC1A-MS,
SMC3-MS, and WT LCLs (Figure S5B), which is consistent with
the absence of PKR activation in SMC1A-MS and SMC3-MS
LCLs. Given the reduced expression of both m6A methyltrans-
ferases in the NIPBL-MS LCL, we then tested whether RNAs
derived from this line had lower levels of m6A modification. We
first performed RNA fractionation outlined in Figure 5C to sepa-
rate the total RNA into three main groups as follows: (1) mRNAs
containing a polyA tail; (2) rRNAs (>80%) and some ncRNAs
following removal ofmRNA; and (3) ncRNAs, for example, tRNAs,
small nuclear RNAs (snRNAs), and small nucleolar RNAs
(snoRNAs), after removal ofmRNAand rRNA through ribo-deple-
tion. We then measured m6A levels in the three groups of RNAs
using an ELISA-based methylation detection method. We found
that all three groups of RNAs isolated from the NIPBL-MS LCL
showed significant reduction in m6A modification compared to
the same groups of RNAs isolated from a WT LCL (Figure 5D).
The decrease was especially striking (more than 6-fold) in the
ncRNA fraction, which would include tRNAs. tRNAs are the
most highly modified RNA species (Phizicky and Hopper, 2010)
and would, therefore, be most likely to show a defect.
We further studied whether the three different RNA fractions
isolated from the NIPBL-MS LCLs stimulated PKR in vitro. We
performed PKR activation assays with 10 ng RNA from each
fraction, using poly I:C as a positive control for PKR activation
(Figure 5E). We found that the rRNA fraction from the NIPBL-
MS LCLs was a strong activator of PKR, followed by thencRNAs. The p-PKR/PKR ratio of NIPBL-MS rRNA (lane 7)
compared to WT rRNA (lane 4) was 5.6 ± 1.3 higher
(p < 0.001). The results suggested that rRNAs from the NIPBL-
MS LCL are potent activators of PKR. The activation could be
based on the lack of m6A modification, other modifications, or
even misfolding (Heinicke and Bevilacqua, 2012), due to the
underexpression of various genes involved in RNA modification
and processing.
We next tested whether RNA from other NIPBL or HDAC8
mutant LCLs could activate PKR activity in vitro. Since rRNAs
from the NIPBL-MS LCL most significantly activate PKR and
rRNAs represent the majority of RNA in cells, total RNA was
used in these in vitro assays. As shown in Figure 5F, total RNA
from NIPBL-NS and NIPBL-FS, as well as from both HDAC8
mutant cell lines, could activate PKR. Taken together, defects
in RNA biogenesis may, therefore, serve as an underlying mech-
anism to activate the PKR-mediated stress response in NIPBL
and HDAC8 mutant LCLs.
DISCUSSION
The data presented here are consistent with a working model in
which NIPBL activates the expression of RNA-processing genes
to promote RNA biogenesis (Figure 6). With the loss of NIPBL
function, either via mutation or knockdown, these genes are
expressed at lower levels. Defects in RNA biogenesis, including
lower levels of m6A modification, lead to the activation of PKR,
triggering a stress response. Inhibition of PKRwith 7DG provides
partial repressionof that stress response.Wehave therefore iden-
tified a previously unknown pathway that could contribute to theCell Reports 14, 93–102, January 5, 2016 ª2016 The Authors 97
Figure 5. RNADerived fromNIPBL-MSCells
Contains Less m6A Modification and These
RNAs Activate PKR In Vitro
(A) qPCR shows the lower expression of METTL3
andMETTL14 RNA in NIPBL-MS cells. Ubiquitin C
served as a loading control. *p < 0.05 and
**p < 0.01 compared to WT.
(B) The reduction of METTL3 andMETTL14 protein
expression is shown in western blots.
(C) The scheme used to fractionate RNA is
diagrammed. The mRNAs are first isolated from
the total RNA, followed by ncRNAs and rRNAs (see
Experimental Procedures for details).
(D) m6A levels are significantly reduced in
mRNAs, ncRNAs, and rRNAs from NIPBL-MS
cells compared to WT cells. There is an es-
pecially dramatic decrease (more than 6-fold) in
m6A levels in the ncRNAs of the NIPBL mutant
LCLs. **p < 0.01 and ***p < 0.001 compared
to WT.
(E) Both ncRNAs and rRNAs isolated from NIPBL-
MS LCLs are capable of activating recombinant
PKR in vitro; 10 ng Poly I:C was used as a positive
control for PKR activation. *p < 0.001 compared to
untreated control; #p < 0.001 compared to WT
rRNA.
(F) Total RNA isolated from NIPBL-NS and NIPBL-FS, and HDAC8 (98P) and HDAC8 (7P) can induce PKR activation in vitro; 1 ng Poly I:C was
used as a positive control for PKR activation. For (E) and (F), 10 ng RNA was used in each reaction.molecular etiology of CdLS. Related cellular stress pathways
have been shown to contribute to pathogenesis in Alzheimer’s
andHuntington’s diseases. The results of our study (1) provide in-
sights into the role of NIPBL in ncRNA biogenesis and (2) reveal
that RNA biogenesis defects, such as lower levels of m6Amethyl-
ation, could trigger stress associated with NIPBLmutations.
This study suggests that stress created by defects in RNA
biogenesis and an upregulation of PKR activity may be a contrib-
uting factor for cellular defects in LCLs derived frompatients with
CdLS. Eukaryotic RNAs are demarcated with a variety of modi-
fications, including 5mC,m5U, s2U,m6A,J, or 20-O-methylation,
which mark them as self, as compared to the unmodified RNAs
from viruses and bacteria, which can be identified as non-self.
For example, human rRNA has ten times more pseudouridine
(J) and 25 times more 20-O-methylated nucleosides than bacte-
rial rRNA (Margulis and Chapman, 1998). This striking difference
in modifications helps account for why bacterial and viral RNAs
are immunogenic, even though they have the same chemical
structure as human RNAs. Previous studies in vitro in human
dendrite cells (Kariko´ et al., 2005) and in vivo in mice (Kormann
et al., 2011) confirmed that RNA with modifications could signif-
icantly suppress immune responses and inflammatory cytokine
formation compared to unmodified RNA. In addition to the
downregulation of the genes encoding the methylation enzymes
METTL3 and METTL14, in both the NIPBL-MS LCL and the
shRNA knockdown of Nipbl in mESCs, genes encoding the en-
zymes needed for pseudouridylation were significantly downre-
gulated, suggesting that the absence of multiplemodifications or
defects may synergize in the activation of PKR. It will be inter-
esting to explore and characterize additional RNA biogenesis
defects and how they contribute to cellular phenotypes in
CdLS in the future.98 Cell Reports 14, 93–102, January 5, 2016 ª2016 The AuthorsRNA modifications such as m6A serve various functions in
regulating cellular processes. For example, it has been proposed
that m6A methylation maintains stem cell pluripotency by pro-
moting the decay of RNAs encoding developmental regulators
(Wang et al., 2014). Knockdown ofMettl3 andMettl14 in mESCs
results in the loss of their self-renewal ability (Wang et al., 2014).
Similar phenotypes, upon Nipbl knockdown, have been re-
ported, including differentiation and increased expression of dif-
ferentiation genes (Kagey et al., 2010). These results suggest
that the cell differentiation induced by Nipbl knockdown may
be partially due to the lack of m6A methylation.
NIPBL and cohesin may contribute to gene expression in
different ways. For instance, NIPBL may be involved in the main-
tenance of NFRs, while cohesin may be important in long-dis-
tance interactions. Due to these different molecular functions,
loss of function may not have equivalent effects on gene expres-
sion. For example, the gene expression profiles of cells upon
NIPBL or cohesin knockdown are different (Muto et al., 2011;
Zuin et al., 2014). Our study further supports this idea since
CdLS LCLs with mutations in SMC1A or SMC3 do not show
PKR activation. A previous study showed that NIPBL directly in-
teracts with histone-deacetylating enzymes HDAC1 and HDAC3
in human cells (Jahnke et al., 2008), suggesting that NIPBL may
initiate the chromatin-remodeling processes through the recruit-
ment of these HDACs in transcriptional regulation. The budding
yeast ortholog of NIPBL, SCC2, may participate in transcrip-
tional regulation by maintaining NFRs through the association
with remodels the structure of chromatin (RSC; Lopez-Serra
et al., 2014). In the future, it will be important to continue to
dissect the molecular role of NIPBL and cohesin in gene expres-
sion, since this knowledge will help us understand how loss of
function leads to human disease.
Figure 6. Model for the Activation of PKR in
LCLs Derived from Individuals with Muta-
tions in NIPBL
NIPBL binds to the promoter/TSS of RNA-pro-
cessing genes, including METTL3 and METTL14,
to promote their expression. The RNA-processing
genes are essential for the RNAmodifications such
as m6Amethylation (red circle), pseudouridylation,
etc. In normal cells, RNAs are highly modified with
m6A methylation and other modifications to pre-
vent activation of PKR. However, in CdLS LCLs
with loss of NIPBL function, RNA-processing
genes are expressed at lower levels. RNAs are
generated that contain less m6A modification and
potentially other modifications as well. Such
aberrant RNAs cause the activation of PKR that is
marked by both dimerization and auto-phosphor-
ylation.In summary, we suggest that NIPBL facilitates a gene expres-
sion program compatible with normal RNA biogenesis. Upon
NIPBL loss of function, there is reduced expression of RNA-pro-
cessing genes, which correlates with the generation of unmodi-
fied RNAs, including m6A deficiency. Such aberrant ncRNAs
could activate the PKR-signaling cascade, leading to poor cell
proliferation, protein synthesis, and apoptosis. Importantly,
treatment with a PKR inhibitor can partially rescue these defects.
The findings shed light on the molecular etiology of CdLS by
highlighting the activation of PKR in the NIPBL and HDAC8
mutant cells. Identification of elevated PKR activity suggests a
new avenue for disease management, namely the use of PKR in-
hibitors to ameliorate cellular stress associated with CdLS.
EXPERIMENTAL PROCEDURES
qRT-PCR and RNA-Seq Analysis
Total RNA from LCLs andmESCs was isolated with TRIzol Reagent (Life Tech-
nologies, 15596) following the manufacturer’s instructions. RNA was treated
with DNase I (New England Biolabs, M0303S) to remove contaminating
genomic DNA. cDNA was synthesized with iScript cDNA Synthesis Kit (Bio-
Rad, 170-8890). The cDNA was then mixed with primers and Power SYBR
Green Master Mix (Life Technologies, 4367659). The gene expression levels
were determined by the AppliedBiosystems 7900HT Fast Real-Time PCRSys-
tem (Life Technologies), followed by normalization to the housekeeping genes
ATP synthase b-subunit (ATP5B) and ubiquitin C (UBC). See Tables S1 and S2
for primers used for human and mouse, respectively.
For RNA-seq of LCLs and MEFs, total RNA was depleted of rRNA with the
Ribo-Zero kit (Epicenter). The ribo-depleted RNA samples were amplified
with the TruSeq RNA Sample Prep Kit (Illumina) for Solexa sequencing. Reads
from two biological replicates for WT and NIPBL-MS were aligned to the hu-
man genome UCSC hg19 and to gene annotation from Ensembl 78 using
TopHat 2.0.10 (Trapnell et al., 2009). Similarly, reads from three biological rep-
licates for WT and Nipbl+/ were aligned to the mouse genome UCSC mm10
and to gene annotations from Ensembl 72 using TopHat 2.0.10. For both
LCLs and MEFs, the differential expression analysis at FDR < 0.05 and the
assessment of statistically significant read coverage for each gene were per-
formed with edgeR (Robinson et al., 2010).Cell Reports 14, 93–1ChIP-Seq Analysis
For LCLs, reads from ChIP-seq experiments were
aligned to the human genome UCSC hg19 using
Bowtie2 aligner 2.1.0, allowing uniquely mapped
reads only up to two mismatches (Langmeadet al., 2009). For mESCs, reads from ChIP-seq experiments were aligned to
themouse genomeUCSCmm10 using Bowtie2 aligner 2.1.0, allowing uniquely
mapped reads only up to two mismatches (Langmead et al., 2009). For both
LCLs and mESCs, reads were extended to 150 bp toward the interior of the
sequenced fragment and normalized to total reads aligned. The average
coverage was binned in 25-bp intervals. Peak calling was performed using
MACS 2.0.10 (Zhang et al., 2008) with stringent conditions to determine statisti-
cal enrichment at an FDR < 1e9, resulting in high-confidence peaks that were
used for subsequent analysis and for depicting enrichment profiles. NIPBL
peaks spanning 2 kb on both sides of the TSSs were binned into 100-bp win-
dows for analysis. Peak annotation was done using HOMER algorithm (Heinz
et al., 2010). GO analysis was performed using DAVID (Huang da et al., 2009).
ThebackgroundGO termswere the union of biological processes, cellular com-
ponents, andmolecular functions. An FDR cutoff of 0.01 was used to select en-
riched terms. GO term clustering was done using REVIGO (Supek et al., 2011).
Generation of LCLs
Human LCLs were generated from patients with mutations in NIPBL, SMC1A,
SMC3, or HDAC8 under an IRB-approved protocol of informed consent. The
mutations were identified by sequencing (Liu et al., 2009).
Cell Culture Conditions
Human LCLs
LCLs were grown in a T25 flask with RPMI media supplemented with 20% fetal
bovine serum (FBS). Fresh media were added daily for expansion.
mESCs
V6.5 mESCs (Novus Biologicals) were grown on irradiated MEFs. Cells
(8.6 3 106) were grown on 0.1% gelatinized (STEMCELL Technologies,
07903) 150-mm tissue culture plates in ESC-c medium consisting of the
following: DMEM supplemented with 15% FBS (HyClone, SH30070.03); 13
b-mercaptoethanol (Millipore, ES-007-E); nonessential amino acids
(STEMCELL Technologies, 07600); 13 GlutaMAX (STEMCELL Technologies,
07100); and50mg/mlpenicillin/streptomycin (STEMCELLTechnologies, 07500).
Irradiated MEFs
Low-passage irradiated MEFs were grown on 150-mm tissue culture plates
48 hr prior to seeding the mESCs in the ESC-c media described above.
MEFs Isolation and Culture
Embryos (14.5 days post-coitum [DPC]) were dissected from one pregnant
mouse and the embryo’s limbs, brain, and internal organs were carefully02, January 5, 2016 ª2016 The Authors 99
removed. The rest of the embryos were then minced into small pieces with a
sterile surgical blade. The minced embryo was then incubated in a 50-ml
tube with 3 ml trypsin for30 min at 37C with the occasional stir. MEF media
(10 ml) were added to the 50-ml tube and mixed well before plating onto a ge-
latinized 10-cm tissue culture dish. After 3–5 days of culture, all cells were
frozen down at 2 3 106 per vial at post-natal day (P)1. MEFs were grown in
DMEM (Sigma, D6546) supplemented with 10% FBS (Gibco, 10437-077). Me-
dium was changed every 2 days. Cells from the third passage were used for
RNA isolation for sequencing.
Lentivirus-Based RNAi Knockdown in mESCs
Lentiviral particle preparation and infection were performed as previously
described with some modifications (Lin et al., 2013). Briefly, 70% confluent
HEK293T cells in a 150-mm tissue culture plate were co-transfected with
8 mg mouse Nipbl shRNA construct (Open Biosystems, TRCN0000124037)
or GFP shRNA (Addgene, 30323), 6 mg psPAX2 packaging plasmids (Addgene,
12260), and 2 mg pMD2.G envelop plasmids (Addgene, 12260) with 40 ml Lip-
ofectamine 2000 (Life Technologies, 11668027). The ESC-c medium was re-
placed after 16 hr of transfection. The medium containing lentiviral particles
was collected 48 and 72 hr after the transfection. The medium was filtered
through 0.45-mm syringe filters (Nalgene) and concentrated by ultra-centrifuge
at 25,000 rpm in an SW-41Ti rotor (Beckman Coulter) for 2 hr at 4C. The V6.5
mESCs were infected with concentrated lentiviral particles in ESC-c medium
containing 8 mg/ml polybrene (Sigma, H9268). Then 24 hr after infection, the
media were replaced with 2 mg/ml puromycin (InvivoGen, ant-pr-1) for
5 days to select for stable integration of the shRNA construct. The medium
with puromycin was changed daily. The GFP and NIPBL knockdown cells
were grown one passage off feeders before harvesting for protein extraction
and RNA isolation.
Western Blots
Western blots were performed as described previously (Yuen et al., 2011).
Briefly, the whole-cell extracts from mESCs or LCLs were isolated by ice-
cold lysis buffer consisting of the following: 50 mM HEPES (pH 7.9), 5 mM
MgCl2, 0.2% Triton, 20% Glycerol, 300 mM NaCl, and proteinase inhibitor
cocktail tablet (Roche, 04693116001). The lysates were incubated on ice for
30 min and then centrifuged at 20,000 3 g for 20 min at 4C. The supernatant
was collected and analyzed for protein concentration using the Lowry method
(Bio-Rad, 500-0111). For each sample, 25 mg total protein was electrophor-
esed under reducing conditions through a NuPAGE 4%–12% Bis-Tris protein
gel (Life Technologies, NP0322BOX). The resolved proteins were electroblot-
ted on an immobilon-P polyvinylidene difluoride membrane (Millipore,
IPVH00010) using wet transfer at 100 V for 90 min at 4C. The membranes
were blocked with 1% BSA in 0.5% Tween-20 PBS (PBST) for 60 min before
an overnight incubation with primary antibodies at 4C. The membranes were
then probed with a horseradish peroxidase-conjugated secondary antibody at
a dilution of 1:3,000 for 1 hr at room temperature. The membranes were devel-
oped with an enhanced chemiluminescence detection system (ECL reagents;
Thermo Scientific, 32132) and then exposed to X-ray films. The signal inten-
sities were quantified using ImageJ (NIH) and normalized with the house-
keeping protein a-tubulin.
Apoptosis Assays
Annexin V was used to study apoptosis of LCLs. First, WT and NIPBL-MS and
NIPBL-NS cells were washed in cold PBS and pelleted by centrifugation, fol-
lowed by re-suspension with annexin-binding buffer consisting of the
following: 10 mM HEPES, 140 mM NaCl, and 2.5 mM CaCl2. The cells were
then stained with DAPI for 10 min at room temperature. After that, 5 ml annexin
V conjugated with Alexa Fluor 488 dye (Life Technologies, A13201) was added
to the cell suspension and incubated at room temperature for 15 min. The
stained cells were assayed quickly with MACSQuant (Miltenyi Biotec). Data
analysis was performed with FlowJo software (Tree Star).
ROS Assays
The levels of ROS in WT, NIPBL-MS, and NIPBL-NS cells, treated with 300 nM
7DG or untreated for 24 hr were determined with the DCFDA-Cellular Reactive
Oxygen Species Detection Assay Kit (Abcam, ab113851), following the manu-100 Cell Reports 14, 93–102, January 5, 2016 ª2016 The Authorsfacturer’s instructions. Briefly, cells were washed in PBS, followed by staining
with 20 mM DCFDA and incubation for 30 min at 37C. The stained cells were
analyzed immediately using MACSQuant at excitation 485 nm/emission
535 nm. Data analysis was performed with FlowJo.
RNA Fractionation
Total RNAs from WT and NIPBL-MS LCLs were isolated with TRIzol Reagent.
First the RNAs with polyA tails were separated from the rest of the RNA using
the polyA spin mRNA isolation kit (NEB, S1560S), following the suggested pro-
tocol. The resulting RNA that mainly consisted of rRNA was divided into two
portions. One portion of this RNA sample was subjected to ribo-depletion us-
ing the Ribo-Zero rRNA Removal kit (Epicenter, MRZH116), resulting in a pool
of RNAs enriched for ncRNAs such as tRNAs, microRNAs, and snoRNAs.
m6A Methylation Assays
To perform m6A methylation assays, 200 ng of each mRNA, ncRNA, and rRNA
fraction was used. The m6A methylation levels of the RNA fractions from WT
andNIPBL-MS cells were determined using the EpiQuikm6A RNAMethylation
Quantification Kit (Epigentek, P-9005-48), according to the manufacturer’s in-
structions. Briefly, a standard curve was prepared by making six different con-
centrations of the positive control, ranging from 0.01 to 0.5 ng/ml. RNA samples
were added to the strip wells anchored on a 96-well plate. The plate was gently
tilted and shaken several times to allow the RNA to bind evenly to the bottom of
the wells. The plate was then sealed and incubated at 37C for 90 min. After
that, the wells were washed three times with 150 ml washing buffer. Capture
antibody diluted 1:1,000 was added to the wells and incubated at room tem-
perature for 60 min, followed by washing three times with 150 ml washing
buffer. Detection antibody with 1:2,000 dilution was then added to each well
for detecting the antibody. The plate was incubated at room temperature for
30 min, followed by washing four times with 150 ml washing buffer. Enhancer
solution diluted 1:5,000 was added to each well and incubated at room tem-
perature for 30 min, followed by washing five times with 150 ml washing buffer.
Detection solution (100 ml) was then added to each well and incubated at room
temperature away from light for 10 min. After that, 100 ml stop solution was
added to quench the enzyme reaction. The absorbance was taken with a mi-
croplate reader at 450 nm within 15 min. The amount of m6A was calculated
with the following equation:
m6AðngÞ=OD : Sample -- OD : Background
Slope of standard curve
PKR Activation Assays In Vitro
PKR activation assays were performed as described (Zheng and Bevilacqua,
2004). RNAs from WT and mutant LCLs were tested for the ability to directly
activate PKR protein in vitro, which was determined by levels of PKR phos-
phorylation in western blots. Briefly, 0.1 ng recombinant PKR (Life Technolo-
gies, PV4821) was dephosphorylated by treating with l-PPase (NEB,
P0753S) for 30 min at 37C. l-PPase was inactivated by treatment with freshly
prepared sodium orthovanadate. The dephosphorylated PKR was then incu-
bated with 10 ng RNA from WT and NIPBL-MS, NIPBL-NS, NIPBL-FS, and
HDAC8 mutant cells in the activation buffer (20 mM HEPES [pH 7.5], 4 mM
MgCl2, 100 mM KCl, and 1 mM ATP) for 3 hr at 30
C. Reactions were stopped
by adding SDS loading buffer and PKR was resolved on a NuPAGE 4%–12%
Bis-Tris protein gel. The phosphorylation of PKR was determined with p-PKR
antibodies (Abcam, ab32036).
Cell Proliferation Assays
WT, NIPBL-MS, and NIPBL-NS LCLs (33 105) were set in a six-well plate with
RPMIwith 20%FBS; 300mM7DGwas supplied in themedium for some LCLs;
and 10 ml cells was used to perform cell counting using the TC20 Automated
Cell Counter (Bio-Rad, 145-0102) daily for 6 days. The experiments were
done in triplicate.
35S methionine Metabolic Labeling Assays
The metabolic labeling assays for proteins have been described previously
(Xu et al., 2013). Briefly, WT and NIPBL-MS LCLs were washed in PBS twice;
switched to 3 ml Met/Cys-free RPMI containing 10 mM MG-132, a
proteasome inhibitor; and pulsed with 30 mCi 35S-methionine. Cells were
lysed in RIPA buffer (50 mM Tris [pH 7.2], 150 mM NaCl, 1% sodium deox-
ycholate, 0.1% SDS, 1% Triton X-100, 10 mM NaF, and 1 mM Na3VO4). Pro-
teins were precipitated by the addition of hot 10% trichloroacetic acid. After
centrifugation, the precipitate was washed twice in acetone. The precipitate
was dissolved in 100 ml 1% SDS and heated at 95C for 10 min. An aliquot of
the SDS extract was counted in Ecoscint for 35S radioactivity in a liquid scin-
tillation spectrometer to determine the amount of 35S-methionine incorpo-
rated into proteins.
Antibodies
Primary antibodies for NIPBL were purchased from Bethyl (A301-799A);
p-PKR (ab32036), METTL3 (ab49253), METTL14 (ab98166), and a-tubulin
(ab15246) were purchased from Abcam; PKR was purchased from Santa
Cruz Biotechnology (sc-6268); and p-eIF2a (3398), eIF2a (9722), and ATF4
(11815) were purchased from Cell Signaling Technology.
ChIP-Seq Data Analyzed in This StudyChIP-Seq
Dataset
Accession Number Reference
Human LCL
NIPBL
SRA:
ERR139553
Mapping of the cohesin loading
factor NIPBL in the human
genome yields insights in
Cornelia de Lange syndrome
(I.D.K., unpublished data)Statistical Analysis
All experiments were repeated independently at least in triplicate, and the data
are presented asmean ± SD. Statistical significance was determined using the
Student’s t test. A p value of < 0.05 was considered to be statistically
significant.
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